Article Details
Retrieved on: 2024-05-13 21:14:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
FORECAST CHANGESRECOMMENDATIONSWall Street's median 12-month price target for Theravance Biopharma Inc is $15.00 This summary was machine ...
Article found on: www.tradingview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here